After gains of 1.4% this morning, CVS Health shares are now trading at $58.35. Read below for the essential facts about this stock:
-
CVS Health has logged a -13.0% 52 week change, compared to 26.2% for the S&P 500
-
CVS has an average analyst rating of buy and is -1.72% away from its mean target price of $59.37 per share
-
Its trailing earnings per share (EPS) is $5.62, which brings its trailing Price to Earnings (P/E) ratio to 10.4. The Consumer Staples sector's average P/E ratio is 22.08
-
The company's forward earnings per share (EPS) is $6.69 and its forward P/E ratio is 8.7
-
The company has a Price to Book (P/B) ratio of 0.98 in contrast to the Consumer Staples sector's average P/B ratio is 3.05
-
The current ratio is currently 0.9, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
CVS has reported YOY quarterly earnings growth of -4.8% and gross profit margins of 0.1%
-
The company's free cash flow for the last fiscal year was $10.4 Billion and the average free cash flow growth rate is 3.8%
-
CVS Health's revenues have an average growth rate of 9.7% with operating expenses growing at 25.2%. The company's current operating margins stand at 3.8%